ID | Sex | Age | Neoadjuvant therapy | RCPath | Resection tissue | Staging | ||
---|---|---|---|---|---|---|---|---|

T | N | M | ||||||

1 | M | 73 | 50.4/28 + 5fu | A | x | 3 | 2 | 0 |

2 | F | 42 | 54/30 + 5fu | A | x | 2,3 | 1,2 | 0 |

3 | F | 38 | 50.4/28 + 5fu | A | x | 3 | 1 | x |

4 | M | 75 | 54/31 + 5fu | A | x | 3 | 2 | x |

5 | M | 51 | 50.4/28 + 5fu | A | x | 3 | 2 | 0 |

6 | M | 66 | 50.4/28 + 5fu | B | √ | 3 | 0,1 | 0 |

7 | M | 57 | 50.4/28 + 5fu | B | √ | 3 | 1,2 | 0 |

8 | F | 72 | 50.4/28 + 5fu | B | x | 3 | 2 | 0 |

9 | M | 65 | 50.4/28 + 5fu | B | x | 3 | x | x |

10 | M | 65 | 50.4/28 + 5fu | B | x | 3 | 2 | x |

11 | F | 64 | 42.2/20 + 5fu | B | x | 2 | 0 | 0 |

12 | F | 60 | 50.4/28 + 5fu | B | x | 2 | 0 | x |

13 | M | 66 | 50.4/28 + 5fu | B | x | 3 | 2 | 0 |

14 | M | 67 | 50.4/28 + 5fu | B | x | 3 | 1 | 0 |

15 | M | 67 | 54/30 + 5fu | B | x | 3 | 1 | x |

16 | F | 55 | 55.4/30 + 5fu | C | √ | 3 | 2 | 0 |

17 | F | 75 | 45/25 + 5fu/RP | C | x | 3 | 0 | 0 |

18 | M | 70 | 50.4/28 + 5fu | C | √ | 3 | 2 | 0 |

19 | M | 79 | 50.4/28 + 5fu | C | x | 3 | 2 | 0 |

20 | M | 76 | 43.2/25 + 5fu | C | √ | 3 | 2 | 0 |

21 | M | 48 | 50.4/28 + 5fu | C | x | 3 | 0 | 0 |

22 | M | 44 | 50.4/30 + 5fu | C | √ | 3 | 2 | 0 |

23 | M | 47 | 50.4/28 + 5fu | C | √ | 3 | 2 | x |

24 | M | 74 | 50.4/28 + 5fu | C | √ | 3 | 2 | x |

25 | M | 45 | 50.4/28 + 5fu | C | x | 3 | 2 | x |

26 | M | 62 | 50.4/30 + 5fu | C | x | 3 | 1 | x |

27 | M | 64 | 50.4/28 + 5fu | C | x | 3 | 1 | x |

28 | F | 41 | 50.4/28 + 5fu | C | x | 3 | 1 | x |

29 | M | 71 | 50.4/28 + 5fu | C | x | 3 | 2 | x |